97 related articles for article (PubMed ID: 212482)
1. Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements.
Mills BJ; Cooper NR
J Immunol; 1978 Oct; 121(4):1549-57. PubMed ID: 212482
[No Abstract] [Full Text] [Related]
2. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
Beebe DP; Cooper NR
J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
[TBL] [Abstract][Full Text] [Related]
3. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
Leddy JP; Simons RL; Douglas RG
J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
[TBL] [Abstract][Full Text] [Related]
4. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.
Mills BJ; Beebe DP; Cooper NR
J Immunol; 1979 Dec; 123(6):2518-24. PubMed ID: 227957
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
6. Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies.
Hangartner L; Senn BM; Ledermann B; Kalinke U; Seiler P; Bucher E; Zellweger RM; Fink K; Odermatt B; Bürki K; Zinkernagel RM; Hengartner H
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12883-8. PubMed ID: 14569006
[TBL] [Abstract][Full Text] [Related]
7. Vesicular stomatitis virus pseudotype with neutralization antigen of tick-borne encephalitis virus.
Dragúnová J; Greśíková M
Acta Virol; 1986 Jul; 30(4):346-8. PubMed ID: 2876617
[TBL] [Abstract][Full Text] [Related]
8. Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization.
Vasantha S; Coelingh KL; Murphy BR; Dourmashkin RR; Hammer CH; Frank MM; Fries LF
Virology; 1988 Dec; 167(2):433-41. PubMed ID: 2849234
[TBL] [Abstract][Full Text] [Related]
9. The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.
Lefrancios L; Lyles DS
Virology; 1982 Aug; 121(1):157-67. PubMed ID: 6180550
[No Abstract] [Full Text] [Related]
10. Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus.
Charan S; Zinkernagel RM
J Immunol; 1986 Apr; 136(8):3057-61. PubMed ID: 3007610
[TBL] [Abstract][Full Text] [Related]
11. Human complement component C1q inhibits the infectivity of cell-free HTLV-I.
Ikeda F; Haraguchi Y; Jinno A; Iino Y; Morishita Y; Shiraki H; Hoshino H
J Immunol; 1998 Nov; 161(10):5712-9. PubMed ID: 9820553
[TBL] [Abstract][Full Text] [Related]
12. [Serological relation of the VSV/Alagoas virus with other components of the vesicular stomatitis group].
Nozawa CM; Andrade CM
An Microbiol (Rio J); 1978; 23():11-7. PubMed ID: 233607
[No Abstract] [Full Text] [Related]
13. Protective T cell-independent antiviral antibody responses are dependent on complement.
Ochsenbein AF; Pinschewer DD; Odermatt B; Carroll MC; Hengartner H; Zinkernagel RM
J Exp Med; 1999 Oct; 190(8):1165-74. PubMed ID: 10523614
[TBL] [Abstract][Full Text] [Related]
14. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
15. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
Martinez I; Barrera JC; Rodriguez LL; Wertz GW
Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin G independent activation of the classical complement pathway by monosodium urate crystals.
Giclas PC; Ginsberg MH; Cooper NR
J Clin Invest; 1979 Apr; 63(4):759-64. PubMed ID: 438335
[TBL] [Abstract][Full Text] [Related]
17. Adaptability costs in immune escape variants of vesicular stomatitis virus.
Novella IS; Gilbertson DL; Borrego B; Domingo E; Holland JJ
Virus Res; 2005 Jan; 107(1):27-34. PubMed ID: 15567030
[TBL] [Abstract][Full Text] [Related]
18. Biochemistry and biological activity of the complement system.
Surján M
Ann Immunol Hung; 1973; 17():101-15. PubMed ID: 4618445
[No Abstract] [Full Text] [Related]
19. An enzyme-linked immunosorbent assay for the detection of bovine antibodies to vesicular stomatitis virus.
Workman T; Shen D; Woodard L; Yilma T
Am J Vet Res; 1986 Jul; 47(7):1507-12. PubMed ID: 3017162
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of monoclonal antibodies directed against glycoproteins of bovine leukaemia virus.
Orlík O; Bán J; Gieciová E; Altanerová V; Altaner C
Acta Virol; 1993 Oct; 37(5):377-87. PubMed ID: 8184790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
